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Within the pediatric population, the rare aortic aneurysm is most often brought on by 
congenital cardiovascular malformation or connective tissue disorder, trauma, inflamma- 
tory disease, or infection. Thus our 8-year-old patient who had multiple aortic aneurysms 
and evidence of mucopolysaccharidosis presented a doubly unique case. Three and 
one-half months after the patient underwent emergency aortic valve replacement, we 
performed resection and graft replacement of both her descending thoracic aorta and 
thoracoabdominal aorta. Histologic analysis of the aneurysm wall displayed severe 
medial degeneration with large deposits of acid mucopolysaccharides. Subsequent 
evaluation, although negative for connective tissue disorders, showed glycosamino- 
glycans, chondroitin sulfate, and heparan sulfate in the patient's urine. These findings 
are diagnostic for a heterogeneous group of storage diseases termed mucopolysaccha- 
ridoses, although testing of the patient's cultured fibroblasts failed to reveal any 
specific previously described enzymatic defect. After reviewing the literature, we 
believe that this is the first known successfully treated pediatric aortic aneurysm 
associated with mucopolysaccharidosis. (J Vasc Surg 1997;26:704-10.) 
Rare aortic aneurysms in children less than 10 
years of age have been associated with congenital 
cardiovascular malformations, connective tissue dis- 
orders, trauma, inflammatory diseases, or infection. 
Although the onset of mucopolysaccharidosis ccurs 
most often in childhood and sometimes affects the 
cardiovascular system with valvular disorders, previ- 
ously reported characteristics do not include aortic 
aneurysms. 
Mucopolysaccharidoses are a family of genetic 
disorders that are produced by a defect in activity of 
one or more of the lysosomal enzymes that are in- 
volved in the degradation of mucopolysaccharides. 
Urinary excretion of these nondegraded products is 
incrcascd, and accumulation ccurs in the intercellu- 
lar substance of connective tissue. Dermatan sulfate, 
heparan sulfate, and keratan sulfate are the major 
mucopolysaccharides involved in the pathogenesis of
the mucopolysaccharidoses, although other sulfates 
have been isolated. Normally, these disorders are 
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suspected on the basis of clinical manifestations, and 
the diagnosis is then confirmed by the finding of 
mucopolysacchariduria and the deficiency of a spe- 
cific degradation enzyme. The mucopolysaccharido- 
ses are inherited in an autosomal recessive mode, 
except for Hunter syndrome (MPS II), which is an 
X-linked recessive disorder. Bony changes are com- 
mon and are referred to as dysostosis multiplex. Pro- 
gressive mental retardation may result from central 
nervous ystem involvement. The liver, spleen, ten- 
dons, joints, and sldn may be involved. 1In this paper 
we present the first reported case of pediatric multiple 
aortic aneurysms thought o be caused by a muco- 
polysaccharidosis and recount he successful resection 
and graft replacement of these aneurysms using distal 
aortic perfusion and cerebrospinal fluid drainage. 
CASE REPORT 
An 8-year-old girl was referred to our institution in 
February 1994 with a presumed iagnosis of Takayasu's 
syndrome with a large descending thoracic ndthoracoab- 
dominal aortic aneurysm. Previously, in June of 1993, the 
patient had been evaluated at an outside institution for 
persistent fever, anorexia, a 5.44 kg weight loss, joint pain, 
and intermittent eye redness and swelling. She had under- 
gone intravenous antibiotic therapy and an extensive diag- 
nostic work-up. After a 4-week hospitalization, the patient 
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was discharged without a concrete diagnosis on empiric 
doxycycline, ibuprofen, and opthalmic steroids for a mild 
uveitis noted on slit-lamp examination. 
Two months later, she returned to the same outside 
hospital in severe respiratory distress with cardiomegaly 
and pulmonary edema. A transthoracic echocardiogram 
revealed poor myocardial contractility with moderate mi- 
tral and severe aortic regurgitation. She underwent an 
emergent aortic valve replacement with a 19 m m St. Jude 
valve on September 30, 19R4. At that time, biopsies were 
taken from the atrial and ventricular myocardium, from a 
mediastinal lymph node, and from the pulmonary paren- 
chyma. Although the aortic valve did not appear grossly 
inflamed, histologic examination demonstrated myxoma- 
tous changes accompanied by inflammatory cells. The 
lymph node tissue showed reactive hyperplasia, nd the 
myocardial Biopsies were consistent with cellular hypertro- 
phy. The lung biopsy, however, showed vasculitis involv- 
ing small and medium arterioles and venules. During a 
prolonged postoperative r covery, the child was treated 
with steroids for the presumed vasculitic origin of her 
disease and required multidrug therapy for hypertension. A 
follow-up transthoracic echocardiogram demonstrated 
right and left coronary artery aneurysms, as well as an 
aneurysm of the descending thoracic aorta. A magnetic 
resonance imaging study showed thoracic and thoracoab- 
dominal aortic aneurysmal enlargement. She was then re- 
ferred to our institution for evaluation and treatment. 
By this time, the patient had recovered from her previ- 
ous operation and was relatively active. Her blood pressure 
was controlled on nifedipine, captopril, atenolol, and furo- 
semide. She remained anticoagulated with warfarin for her 
prosthetic valve and was continued on prednisone. Her 
weight and height were normal for her age (23.6 kg, 120 
cm), and she was considered to be of normal intelligence. 
She had no craniofacial bnormalities, and a complete ye 
examination was normal without evidence of corneal 
clouding. An approximately 4 cm, firm, pulsatile mass was 
palpable in the midline above the umbilicus. All joints had 
a normal range of motion. Pulses were equal bilaterally in 
the extremities. Her admitting laboratory results, includ- 
ing complete blood count, electrolytes, blood urea nitro- 
gen, creatinine, and partial thromboplastin time, were nor- 
mal. Her prothrombin time was 15.3 seconds. 
Preoperative pulmonary function tests were accept- 
able, and a transthoracic e hocardiogram revealed mild left 
ventricular hypertrophy with an estimated ejection fraction 
of 60% to 69%, normal mitral valve function, and a nor- 
mally functioning prosthetic aortic valve. There was no 
change in the right or left coronary cine aneurysms. Preop- 
erative aortography showed a 5 cm fusiform aneurysm of 
the proximal one-third of the descending thoracic aorta 
beginning just distal to the left subclavian artery (type A) 
and a 4.5 cm thoracoabdominal aortic aneurysm originat- 
ing just above the diaphragm, extending just proximal to 
the aortic bifurcation (type III). A normal-caliber aorta was 
noted between the aneurysmal segments. The ascending 
aorta measured 2.5 cm, and the innominate artery, which 
was mildly ectatic, gave rise to the left common carotid 
artery. On February 16, 1994, the patient underwentre- 
section and graft replacement of the proximal descending 
thoracic aortic aneurysm and of the thoracoabdominal 
aortic aneurysm. 
Operative details. After a general anesthetic was ad- 
ministered, an Opticath pulmonary arterial monitoring 
catheter (Abbott Laboratories, North Chicago, Ill.), upper 
and lower extremity intravenous lines, and left and right 
radial at'terial lines were inserted. A Fogarty catheter placed 
in the left mainstem bronchus permitted left lung collapse. 
A Cordis lumbar drain kit (Cordis Corp., Miami, Fla.) was 
used for cerebrospinal fluid drainage. The patient was 
placed in a lateral position, and a 14-gauge Tuohy needle 
was introduced between L3 and L4. The position of the 
Tuohy needle in the subarachnoid space was confirmed by 
the free flow of cerebrospinal fluid. Pressure was then 
recorded and monitored continuously for the remainder of 
the procedure and drained if it rose above 15 mm Hg. In 
an oblique right lateral decubims fashion, removal of the 
sixth rib followed a left thoracoabdominal incision in the 
sixth intercostal space. The diaphragm was split radially to 
the aortic hiatus, and the abdominal viscera was rotated to 
provide exposure of the entire thoracoabdominal aorta. 
The descending thoracic aneurysm extended from the left 
subclavian artery to the sixth intercostal space (type A 
descending thoracic aortic aneurysm). From the sixth in- 
tercostal space the aorta was normal in diameter and ap- 
pearance until the tenth intercostal space, where a second 
area of aneurysmal dilatation began, extending just proxi- 
mal to the bifurcation (type II I thoracoabdominal aortic 
aneurysm; Fig. 1). 
The left atrium and the distal thoracic aorta were can- 
nulated, and bypass was initiated using the BioMedicus 
pump (BioMedicus, Minneapolis). The aorta was cross- 
clamped istally at the level of the eighth intercostal space 
and proximal to the left subclavian artery, which was sepa- 
rately clamped. After opening the aneurysm, the proximal 
end of the descending thoracic aorta was completely 
transected and isolated from the esophagus. A 20 mm 
woven Dacron tube graft was then sutured to the proximal 
descending thoracic aorta, cut, and sutured to the distal 
descending thoracic aorta at the level of the seventh inter- 
costal space. With flow now restored to the lower intercos- 
tal arteries, attention was turned towards the thoraco- 
abdominal aortic aneurysm. To again maintain distal 
perfusion, the distal end of the BioMedicus pump cannula 
was inserted in the distal infrarenal abdominal orta. With a 
proximal cross-clamp at the level of the eighth intercostal 
space and a distal cross-clamp above the pump cannula, the 
thoracoabdominal aneurysm was opened. The celiac, supe- 
rior lnesenteric, and both renal arteries were cannulated 
with #9 Pruitt catheters for cold visceral perfusion. This 
portion of the aorta was replaced with an 18 mm woven 
Dacron graft first anastomosed at the level of the tenth 
intercostal space. A side hole was cut in the graft, and the 
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Fig. 1. Preoperative descending thoracic and thoracoab- 
dominal aneurysms. 
celiac and superior mesenteric arteries were reimplanted. 
The left renal artery was separately reimplanted after de- 
taching it from the native aorta. The descending thoracic 
aortic clamp was then moved down onto the graft, restor- 
ing flow to the viscera and to the left kidney. The distal 
aortic BioMedicus cannula was removed, and the distal 
aortic graft sutured to the infrarenal aorta just above the 
bifurcation. All of the graft-to-native aorta anastomoses 
were completed using a 3-0 prolene in a continuous over 
and over fashion. The right kidney was then rcvascularized 
using a 10 mm woven Dacron jump graft. An end-to-end 
anastomosis was created from the jump graft to the right 
renal artery orifice, and using a partial occluding clamp on 
the aortic graft the proximal anastomosis was completed in
an end-to-side fashion. A biopsy of the aneurysm wall was 
sent for pathologic examination, and the graft was then 
wrapped with the remaining aneurysm wall. The left 
atrium was decannulated, the diaphragm was repaired, two 
large chest ubes were placed in the pleural space, and the 
left lung was reinflated. The thoracic avity and abdomen 
were closed in the standard fashion. An intraoperative 
transesophageal echocardiogram showed no significant 
change in cardiac function. Fig. 2 shows the completed 
graft replacement of both the descending thoracic and 
thoracoabdominal aortic aneurysms. 
Postoperative course. The patient had an uncompli- 
cated postoperative course and was discharged home on 
Fig. 2. Completed graft replacement of descending tho- 
racic and thoracoabdominal aortic aneurysms with bypass 
graft to right renal artery. 
postoperative day 10. A postoperative magnetic resonance 
imaging study showed satisfactory flow in the graft and 
native aorta and no change in the fight or left coronary 
artery aneurysms. 
Surgical specimens from both the descending thoracic 
and thoracoabdominal aorta were sent for microscopic 
pathologic evaluation (Fig. 3). The aorta was fixed in 10% 
bufered formaldehyde, processed, and stained with hema- 
toxylin and eosin, as well as VerhoeffVon Gieson staining 
for elastic fibers. The specimens were fixed in 3% glutaral- 
dehyde, buffered with 0.1 mol /L  PIPES (piperazine-N, 
N'-bis[2-ethane sulfonic acid]) overnight, rinsed in PIPES 
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Fig. 3. A, Low-power photomicrograph s ows full-thickness aortic wail with cellular intimal 
proliferation. Severe medial degeneration is present, with marked loss of elastic fibers and 
increased acid mucopolysaccharides. (VVG stain; original magnification, 50×). B, Electron 
micrograph of aortic media shows almost total loss of elastic fibers with few fragments 
remaining (EF). Large cell in center is myofibroblast (ME). Other cells are modified smooth 
muscle cells (SM) intermixed with collagen (C). Original magnification, 4000×. 
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Table I. Mucopolysaccharidosis--pathologic and linical characteristics 
Urine 
References Type Enzyme deficiency electrophoresis Clinical characteristics 
Danes and Baern 3 MPSIH ~-L-iduronidase Dermatan sulfate 1. Mental retardation 
Heparan sulfate 2. Coarse facial features 
3. Corneal clouding 
4. Hepatosplenomegaly 
5. Hernias 
6. Joint stiffness 
7. Isyphosis 
MPSIS 1. Normal intelligence 
2. Mild facial coarseness 
3. Corneal clouding 
4. Aortic insufficiency 
5. Normal life span 
1. Normal intelligence 
2. Mild facial coarseness 
3. Corneal clouding 
4. Hepatosplenamegaly 
5. Hernias 
6. Mitral valve insufficiency 
7. Normal life span 
1. Mental retardation 
2. Coarse facial features 
3. Hepatosplenomegaly 
4. Hernias 
5. Joint stiffness 
1. Minimal retardation 
2. Physically similar to MPSIIA 
Danes and Baern 3 c~-L-iduronidase Dermatan sulfate 
Danes and Baern s MPSIH/ IS  a-L-iduronidase Dermatan sulfate 
MPS II type A 
(Hurler syndrome) 
Danes and Baern 3 Iduronosulfate sulfatase Dermatan sulfate 
Heparan sulfate 
Danes and Baern s MPS II type B Iduronosulfate sulfatase Dermatan sulfate 
Heparan sulfate 
3. Airway obstruction 
Van De Kamp et al. 4 MPS III type A Sulfamidase Heparan sulfate <10 years of age: 
(Sanfilippo 1. Delayed developmental 
syndrome) milestones 
2. Hyperactive 
Kresse et al. 6 MPS III type C Acetyl CoA: c*-glucosaminide Heparan sulfate >10 years of age: 
N-acetyl transferase 1. Rapid neurologic 
deterioration 
2. Unsteady gait 
Kresse et al. 7 MPS III type D N-acetylglucosamine-6- Heparan sulfate 3. Joint stiffness 
sulfate sulfatase 4. Hepatosplenomegaly 
5. Hernias 
6. Dysotosis multiplex 
DiFerrante t al. s MPS IV type A Galactosamine-6-sulfate Keratan sulfate 1. Normal intelligence 
(Morquio syndrome) sulfatase 2. Corneal clouding 
Arbisser et al. 9 MPS IV type B 13-Galactosidase Keratan sulfate 3. Hepatosplenomegaly 
4, Aortic insufficiency 
5. Dysostosis multiplex 
DiFerrante t al) ° MPS VI Aryl sulfatase-13 Dermatan sulfate 1. Normal intelligence 
(Maroteaux-Lamy 2. Coarse facial features 
disease) 3. Hepatosplenomegaly 
4. Joint stiffness 
5. Aortic insufficiency 
6. Mitral valve insufficiency 
Sly et al. l ~ MPS VII 13-glucuronidase Chondroitin 1. Mental retardation 
(Sly syndrome) sulfate 2. Hepatosplenomegaly 
3. Hernias 
4. Joint stiffness 
5. Kyphoscofiosis 
Ginsberg et al. ~2 MPS VIII N-acetylglucos-amine-6- Karatan sulfate 1. Mental retardation 
(DiFerrante sulfate-snlfatase Heparan sulfate 2. Blindness 
syndrome) 3. Coarse facial features 
4. Dysostasis multiplex 
Current case Nonclassified Undetected Chondroitin 1. Normal intelligence 
sulfate 2. Aortic insufficiency 
Heparan sulfate 2. Thoracic and 
thoracoabdorninal aortic 
anenrysms 
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buffer, and postfixed in 2% osmium tetroxide, for 1 hour. 
The fixed tissue was then dehydrated through a graded 
series of ethanol and embedded in Spurr's resin in the usual 
manner. One-micrometer sections were stained with an 
alcoholic solution of toluidine blue and basic fuchsin and 
were examined with the light microscope. Ultra-thin sec- 
tions were stained with uranyl acetate and lead citrate and 
were examined ina JEOL 100C electron microscope. Both 
segments showed severe medial degeneration with fibrosis 
and a marked increase in intimal and medial acid muco- 
polysaccharides in all sections. There was severe fragmen- 
tation and partial to complete loss of elastic fibers in all 
sections. There was no evidence of aortitis. 
At the 3-year follow-up the patient remains active. She 
continues to require antihypertensive therapy and required 
replacement of her prosthetic valve as a result of leaflet 
occlusion by thrombus, but is otherwise well. 
Pathologic findings. The pathologic findings 
prompted an investigation for connective tissue disorders 
and inherited isorders of metabolism, which the patient 
underwent on an outpatient basis. A urine metabolite 
screen ,was performed, which was positive for muco- 
polysaccharides (Biochemical Genetics Laboratory, Baylor 
College of Medicine, Houston, Tex.). A qualitative analy- 
sis of urine glycosaminoglycans was obtained using cellu- 
lose acetate lectrophoresis (Jerry N. Thompson, PhD, 
Laboratory of Medical Genetics, University of Alabama t 
Birmingham). Chondroitin sulfate, heparan sulfate, and a 
slow migrating component (presumed to be heparan sul- 
fate) were detected. Cultured skin fibroblasts were exam- 
ined by protein gel electrophoresis fortype I and type III 
collagen biosynthesis and structure (Peter H. Byers, MD, 
Professor, Department ofMedical Genetics, University of 
Washington, Seattle). Both were found to be normal. Skin 
fibroblasts from the patient were also cultured and studied 
for mucopolysaccharide degrading enzyme activity (Jerry 
N. Thompson, PhD, Laboratory of Medical Genetics, 
University of Alabama at Birmingham). The results were 
all within normal limits. 
DISCUSSION 
In this report wc present the case of  an 8-year-old 
girl who was referred with a thoracic and a thoraco- 
abdominal aortic aneurysm 4 months after a diagno- 
sis of  severe aortic insufficicncy and emergency aortic 
valve replacement. Resection and repair of  both 
aneurysms was successfully performed using cere- 
brospinal fluid drainage and distal aortic perfusion 
techniques. Wc have recently presented our data sup- 
porting the use of the above-mentioned a juncts in 
thoracoabdominal aortic surgery and their contribu- 
tion to the reduction of  postoperative paraplegia. 2 
Because aneurysms in the pediatric population 
are rare, we diligently searched for an origin. Table I 
lists the 14 classified types ofmucopolysaccharidoscs, 
their associated enzyme deficiencies, urine electro- 
phoresis findings, and the corresponding clinical 
characteristics. The absence of  an inflammatory re- 
sponse in the aneurysmal segments of  the current 
patient negated the possibility of juvenile arthritis, 
Takayasu's arteritis, or Kawasaki syndrome. The 
presence of severe medial degeneration was similar to 
connective tissue disorders uch as Marfan syndrome 
or Ehlers-Danlos syndrome. However, there were no 
associated abnormalities in type I or type III colla- 
gen. An excess of acid mucopolysaccharides in the 
intima of the resected aortic wall, along with a urine 
metabolite screen that was positive for mucopolysac- 
charides, led to the diagnosis ofa mucopolysacchari- 
dosis. 
Our patient is unusual in comparison with typical 
clinical characteristics for mucopolysaccharidoses; 
she is of  normal intelligence, displays no obvious 
skeletal or craniofacial abnormalities, and was not 
found to have hepatosplenomegaly or corneal cloud- 
ing. The only similarities with any of the currently 
classified mucopolysaccharidoses are her previous 
aortic insufficiency and her history of joint stiffness. 
None of the existing syndromes have been associated 
with the formation of aneurysms. The unique com- 
bination of  chondroitin sulfate and heparan sulfate 
detected by urine electrophoresis in our patient and 
the absence of  a previously described enzyme defi- 
ciency suggest that she has an as yet unclassified form 
of mucopolysaccharidosis that is less severe in terms 
ofneurologic and skeletal manifestations, but signif- 
icant as the origin of life-threatening aortic insuffi- 
ciency and multiple aortic aneurysms. Our review of 
the literature failed to identify any previous cases of  
pediatric aortic aneurysms of this origin. We there- 
fore believe that this is the first case in the pediatric 
population of an aortic anemTsm associated with a 
nonclassified mucopolysaccharidosis that has been 
successfully repaired by resection and graft replace: 
ment. 
We give grateful acknowledgment to Ms. Susan Rob- 
bins and Ms. Mary Hsiao for technical assistance with 
specimen preparation and electron microscopy, and special 
thanks to our editor, Amy Wirtz Newland. 
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